Product Program year 2025 Source: CMS Open Payments

NIM Vital

Device Nerve Monitoring Products

PDI 00763000002992

Open in the dashboard

General payments

$244,203

752 payments

Research payments

$0

0 payments

Through program year 2025, $244,203 in general payments and $0 in research payments were reported against NIM Vital (Nerve Monitoring Products).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $63,492 268
2024 General $129,598 200
2023 General $30,172 173
2022 General $14,554 47
2021 General $6,388 64

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $244,203 752 payments
Top recipients General payments · program year 2025
  1. Gregory Randolph Otolaryngology · Boston, MA $13,260 21% · 5 payments
  2. Ralph Tufano Otolaryngology · Sarasota, FL $6,900 11% · 2 payments
  3. Seilesh Babu Otology & Neurotology · Farmington Hills, MI $6,086 10% · 4 payments
  4. Simon Holoubek Surgery · Rockford, IL $5,716 9% · 5 payments
  5. Jack Kartush Otolaryngology · Farmington Hills, MI $5,600 9% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Otolaryngology $36,695 59% · 103 practitioners
  2. Surgery $9,011 14% · 17 practitioners
  3. Otology & Neurotology Otolaryngology $8,955 14% · 15 practitioners
  4. Clinical Cardiac Electrophysiology Internal Medicine $3,000 5% · 1 practitioner
  5. Plastic Surgery within the Head & Neck Otolaryngology $1,799 3% · 14 practitioners

The top 5 of 27 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Massachusetts $13,406 21% · 3 recipients
  2. Michigan $13,058 21% · 19 recipients
  3. Maryland $6,900 11% · 1 recipient
  4. Illinois $5,081 8% · 7 recipients
  5. Pennsylvania $4,924 8% · 21 recipients

The top 5 of 34 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

752 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record